Epidemiological and experimental data implicate maternal infection and inflammation in the etiology of brain white matter injury, which may lead to cerebral palsy in preterm newborns. Our aim was to investigate motor development of the offspring after maternal administration of lipopolysaccharide (LPS). Wistar rats were intraperitoneally injected with Escherichia coli LPS or saline on gestational days 19 and 20. From birth to 3 weeks, pups were tested for neurobehavioral development, neurological signs and reflexes. From 3 to 6 weeks, motor coordination was investigated. At 4 months, animals were tested for locomotion. Brain myelination was assessed by myelin basic protein immunohistochemistry. Days of appearance of several neurological reflexes were significantly delayed, and neonate LPS pups displayed retarded performance in righting, gait and negative geotaxis. At the juvenile stage, LPS animals showed important impairment in coordination. However, although the LPS group performed worse in most tests, they reached vehicle levels by 5 weeks. At 4 months, LPS animals did not show variations in locomotion performances compared to vehicle. No myelination differences have been observed in the brains at adulthood. Maternal LPS administration results in delayed motor development even though these alterations fade to reach control level by 5 weeks. Motor impairments observed at the early stage in this study could be linked to previously reported hypomyelination of the white matter induced by maternal LPS challenge in the neonates. Finally, the normal myelination shown here at adulthood may explain the functional recovery of the animals and suggest either a potential remyelination of the brain or a delayed myelination in LPS pups.

1.
Khwaja O, Volpe JJ: Pathogenesis of cerebral white matter injury of prematurity. Arch Dis Child Fetal Neonatal Ed 2008;93:F153-F161.
2.
Volpe JJ: Brain injury in premature infants: a complex amalgam of destructive and developmental disturbances. Lancet Neurol 2009;8:110-124.
3.
Wu YW, Colford JM Jr: Chorioamnionitis as a risk factor for cerebral palsy: a meta-analysis. JAMA 2000;284:1417-1424.
4.
Saliba E, Marret S: Cerebral white matter damage in the preterm infant: pathophysiology and risk factors. Semin Neonatol 2001;6:121-133.
5.
Back SA, Rivkees SA: Emerging concepts in periventricular white matter injury. Semin Perinatol 2004;28:405-414.
6.
Bell MJ, Hallenbeck JM, Gallo V: Determining the fetal inflammatory response in an experimental model of intrauterine inflammation in rats. Pediatr Res 2004;56:541-546.
7.
Dammann O, Leviton A: Maternal intrauterine infection, cytokines, and brain damage in the preterm newborn. Pediatr Res 1997;42:1-8.
8.
Dammann O, Leviton A: Role of the fetus in perinatal infection and neonatal brain damage. Curr Opin Pediatr 2000;12:99-104.
9.
Plaisant F, Dommergues MA, Debillon T, Gressens P: Pathophysiology of periventricular leukomalacia. Arch Pediatr 2005;12:734-736.
10.
Marret S, Marpeau L: Grand prematurity, risk of neuropsychic handicaps and neuroprotection. J Gynécol Obstét Biol Reprod 2000;29:373-384.
11.
Nelson KB: The epidemiology of cerebral palsy in term infants. Ment Retard Dev Disabil Res Rev 2002;8:146-150.
12.
Nelson KB, Willoughby RE: Infection, inflammation and the risk of cerebral palsy. Curr Opin Neurol 2000;13:133-139.
13.
Lubics A, Reglodi D, Tamas A, Kiss P, Szalai M, Szalontay L, Lengvari I: Neurological reflexes and early motor behavior in rats subjected to neonatal hypoxic-ischemic injury. Behav Brain Res 2005;157:157-165.
14.
Wang LS, Zhou J, Shao XM, Tang XC: Huperzine A attenuates cognitive deficits and brain injury in neonatal rats after hypoxia-ischemia. Brain Res 2002;949:162-170.
15.
Golan H, Kashtutsky I, Hallak M, Sorokin Y, Huleihel M: Maternal hypoxia during pregnancy delays the development of motor reflexes in newborn mice. Dev Neurosci 2004;26:24-29.
16.
Derrick M, Luo NL, Bregman JC, Jilling T, Ji X, Fisher K, Gladson CL, Beardsley DJ, Murdoch G, Back SA, Tan S: Preterm fetal hypoxia-ischemia causes hypertonia and motor deficits in the neonatal rabbit: a model for human cerebral palsy? J Neurosci 2004;24:24-34.
17.
Bilbo SD, Levkoff LH, Mahoney JH, Watkins LR, Rudy JW, Maier SF: Neonatal infection induces memory impairments following an immune challenge in adulthood. Behav Neurosci 2005;119:293-301.
18.
Roberson R, Woodard JE, Toso L, Abebe D, Poggi SH, Spong CY: Postnatal inflammatory rat model for cerebral palsy: too different from humans. Am J Obstet Gynecol 2006;195:1038-1044.
19.
Fortier ME, Joober R, Luheshi GN, Boksa P: Maternal exposure to bacterial endotoxin during pregnancy enhances amphetamine-induced locomotion and startle responses in adult rat offspring. J Psychiatr Res 2004;38:335-345.
20.
Poggi SH, Park J, Toso L, Abebe D, Roberson R, Woodard JE, Spong CY: No phenotype associated with established lipopolysaccharide model for cerebral palsy. Am J Obstet Gynecol 2005;192:727-733.
21.
Toso L, Poggi S, Park J, Einat H, Roberson R, Dunlap V, Woodard J, Abebe D, Spong CY: Inflammatory-mediated model of cerebral palsy with developmental sequelae. Am J Obstet Gynecol 2005;193:933-941.
22.
Kannan S, Saadani-Makki F, Balakrishnan B, Chakraborty P, Janisse J, Lu X, Muzik O, Romero R, Chugani DC: Magnitude of [(11)C]PK11195 binding is related to severity of motor deficits in a rabbit model of cerebral palsy induced by intrauterine endotoxin exposure. Dev Neurosci 2011;33:231-240.
23.
Saadani-Makki F, Kannan S, Lu X, Janisse J, Dawe E, Edwin S, Romero R, Chugani D: Intrauterine administration of endotoxin leads to motor deficits in a rabbit model: a link between prenatal infection and cerebral palsy. Am J Obstet Gynecol 2008;199:651, e651-e657.
24.
Liu Y, Wu Y, Lee JC, Xue H, Pevny LH, Kaprielian Z, Rao MS: Oligodendrocyte and astrocyte development in rodents: an in situ and immunohistological analysis during embryonic development. Glia 2002;40:25-43.
25.
Rousset CI, Chalon S, Cantagrel S, Bodard S, Andres C, Gressens P, Saliba E: Maternal exposure to LPS induces hypomyelination in the internal capsule and programmed cell death in the deep gray matter in newborn rats. Pediatr Res 2006;59:428-433.
26.
Fox WM: Reflex-ontogeny and behavioural development of the mouse. Anim Behav 1965;13:234-241.
27.
Smart JL, Dobbing J: Vulnerability of developing brain. 6. Relative effects of foetal and early postnatal undernutrition on reflex ontogeny and development of behaviour in the rat. Brain Res 1971;33:303-314.
28.
Smart JL, Dobbing J: Vulnerability of developing brain. 2. Effects of early nutritional deprivation on reflex ontogeny and development of behaviour in the rat. Brain Res 1971;28:85-95.
29.
Altman J, Sudarshan K: Postnatal development of locomotion in the laboratory rat. Anim Behav 1975;23:896-920.
30.
Dam K, Seidler FJ, Slotkin TA: Chlorpyrifos exposure during a critical neonatal period elicits gender-selective deficits in the development of coordination skills and locomotor activity. Brain Res Dev Brain Res 2000;121:179-187.
31.
Hill JM, Gozes I, Hill JL, Fridkin M, Brenneman DE: Vasoactive intestinal peptide antagonist retards the development of neonatal behaviors in the rat. Peptides 1991;12:187-192.
32.
Rosenblatt JS: Prepartum and postpartum regulation of maternal behaviour in the rat. Ciba Found Symp 1975;33:17-37.
33.
Paxinos G, Watson C: The Rat Brain in Stereotaxis Coordinates. New York, Academic Press, 1986.
34.
Rousset CI, Kassem J, Olivier P, Chalon S, Gressens P, Saliba E: Antenatal bacterial endotoxin sensitizes the immature rat brain to postnatal excitotoxic injury. J Neuropathol Exp Neurol 2008;67:994-1000.
35.
Bull DF, Brown R, King MG, Husband AJ: Modulation of body temperature through taste aversion conditioning. Physiol Behav 1991;49:1229-1233.
36.
Wang X, Rousset CI, Hagberg H, Mallard C: Lipopolysaccharide-induced inflammation and perinatal brain injury. Semin Fetal Neonatal Med 2006;11:343-353.
37.
Ferrari F, Todeschini A, Guidotti I, Martinez-Biarge M, Roversi MF, Berardi A, Ranzi A, Cowan FM, Rutherford MA: General movements in full-term infants with perinatal asphyxia are related to basal ganglia and thalamic lesions. J Pediatr 2011;158:904-911.
38.
Stewart RM: Observations on the pathology of cerebral diplegia. [Abridged.]: President's address. Proc R Soc Med 1942;36:25-32.
39.
Favrais G, van de Looij Y, Fleiss B, Ramanantsoa N, Bonnin P, Stoltenburg-Didinger G, Lacaud A, Saliba E, Dammann O, Gallego J, Sizonenko S, Hagberg H, Lelievre V, Gressens P: Systemic inflammation disrupts the developmental program of white matter. Ann Neurol 2011;70:550-565.
40.
Hicks SP, D'Amato CJ: Motor-sensory cortex-corticospinal system and developing locomotion and placing in rats. Am J Anat 1975;143:1-42.
41.
Huttenlocher PR, Bonnier C: Effects of changes in the periphery on development of the corticospinal motor system in the rat. Brain Res Dev Brain Res 1991;60:253-260.
42.
Huttenlocher PR, Raichelson RM: Effects of neonatal hemispherectomy on location and number of corticospinal neurons in the rat. Brain Res Dev Brain Res 1989;47:59-69.
43.
Baharnoori M, Bhardwaj SK, Srivastava LK: Neonatal behavioral changes in rats with gestational exposure to lipopolysaccharide: a prenatal infection model for developmental neuropsychiatric disorders. Schizophr Bull 2012;38:444-456.
44.
Dean JM, Riddle A, Maire J, Hansen KD, Preston M, Barnes AP, Sherman LS, Back SA: An organotypic slice culture model of chronic white matter injury with maturation arrest of oligodendrocyte progenitors. Mol Neurodegener 2011;6:46.
45.
Billiards SS, Haynes RL, Folkerth RD, Borenstein NS, Trachtenberg FL, Rowitch DH, Ligon KL, Volpe JJ, Kinney HC: Myelin abnormalities without oligodendrocyte loss in periventricular leukomalacia. Brain Pathol 2008;18:153-163.
46.
Buser JR, Maire J, Riddle A, Gong X, Nguyen T, Nelson K, Luo NL, Ren J, Struve J, Sherman LS, Miller SP, Chau V, Hendson G, Ballabh P, Grafe MR, Back SA: Arrested preoligodendrocyte maturation contributes to myelination failure in premature infants. Ann Neurol 2012;71:93-109.
47.
Dean JM, Moravec MD, Grafe M, Abend N, Ren J, Gong X, Volpe JJ, Jensen FE, Hohimer AR, Back SA: Strain-specific differences in perinatal rodent oligodendrocyte lineage progression and its correlation with human. Dev Neurosci 2011;33:251-260.
48.
Mallard C, Welin AK, Peebles D, Hagberg H, Kjellmer I: White matter injury following systemic endotoxemia or asphyxia in the fetal sheep. Neurochem Res 2003;28:215-223.
49.
Girard S, Kadhim H, Beaudet N, Sarret P, Sebire G: Developmental motor deficits induced by combined fetal exposure to lipopolysaccharide and early neonatal hypoxia/ischemia: a novel animal model for cerebral palsy in very premature infants. Neuroscience 2009;158:673-682.
50.
Golan HM, Lev V, Hallak M, Sorokin Y, Huleihel M: Specific neurodevelopmental damage in mice offspring following maternal inflammation during pregnancy. Neuropharmacology 2005;48:903-917.
51.
Hava G, Vered L, Yael M, Mordechai H, Mahoud H: Alterations in behavior in adult offspring mice following maternal inflammation during pregnancy. Dev Psychobiol 2006;48:162-168.
52.
Lowe GC, Luheshi GN, Williams S: Maternal infection and fever during late gestation are associated with altered synaptic transmission in the hippocampus of juvenile offspring rats. Am J Physiol Regul Integr Comp Physiol 2008;295:R1563-R1571.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.